Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies
Crossref DOI link: https://doi.org/10.1245/s10434-022-11709-8
Published Online: 2022-05-05
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Healy, Mark A.
Choti, Michael A.
Text and Data Mining valid from 2022-05-05
Version of Record valid from 2022-05-05
Article History
Received: 16 March 2022
Accepted: 21 March 2022
First Online: 5 May 2022
Disclosures
: Nothing to disclose.
Free to read: This content has been made available to all.